Who
James C. Hamilton
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Arrowhead Pharmaceuticals.
In numbers
- Trades disclosed
- 72
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $18.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jan 2021
- Last trade
- 23 Apr 2026
- Last filed
- 24 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Apr 2026filed 24 Apr 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $750K10,000 at $75.00 | filing |
| 23 Apr 2026filed 24 Apr 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $750K10,000 at $75.00 | filing |
| 5 Mar 2026filed 9 Mar 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $642K10,000 at $64.19 | filing |
| 5 Mar 2026filed 9 Mar 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $642K10,000 at $64.19 | filing |
| 6 Jan 2026filed 8 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $283K4,625 at $61.24 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $379K6,090 at $62.28 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $932K14,792 at $63.01 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $813K12,711 at $63.95 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $77K1,200 at $64.49 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $29K437 at $65.97 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $21K309 at $68.00 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $283K4,625 at $61.24 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $379K6,090 at $62.28 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $932K14,792 at $63.01 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $813K12,711 at $63.95 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $77K1,200 at $64.49 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $29K437 at $65.97 | filing |
| 5 Jan 2026filed 5 Jan 2026 | ARWR Arrowhead PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $21K309 at $68.00 | filing |
News
Head-To-Head Review: DBV Technologies (NASDAQ:DBVT) vs. Arrowhead Pharmaceuticals (NASDAQ:ARWR)ARWR · dailypolitical.com · 21 Oct 2026Arrowhead Pharmaceuticals (NASDAQ:ARWR) versus Sera Prognostics (NASDAQ:SERA) Head to Head ReviewARWR · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name James C. Hamilton; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.